首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Atherosclerosis plus

缩写:ATHEROSCLEROSIS PLUS

ISSN:2667-0909

e-ISSN:2667-0895

IF/分区:2.1/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引142
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Hao Xue,Yu Lin,Youlin Liu et al. Hao Xue et al.
Background: Accurate estimation of low-density lipoprotein cholesterol (LDL-C) is crucial for atherosclerotic cardiovascular disease (ASCVD) risk management. Extensive international validation studies have demonstrated th...
Monika Targońska,Anna Janaszak-Jasiecka,Magdalena Chmara et al. Monika Targońska et al.
Background and aims: Familial hypercholesterolemia is a genetic disorder caused by pathogenic or likely pathogenic variants in four key genes: LDLR, APOB, PCSK9, and APOE. It leads to elevated levels of low-density lipopr...
Xiaowei Yin,Yajie Zhang,Luyao Shi et al. Xiaowei Yin et al.
Aim: Earthworm fibrinolytic enzymes A (EFEa) is the main active component of earthworm fibrinolytic enzymes which possesses anticoagulant, fibrinolytic, and potential anti-atherosclerotic effects. However, the biological ...
Khaled Abdoun,Justin Swanson,Ian Pollack et al. Khaled Abdoun et al.
Introduction: Systemic inflammation is a well-established risk factor for atherosclerotic cardiovascular disease (ASCVD) and has also been implicated in the progression of neuroinflammation. However, the relationship betw...
Alessandro Lupi,Martino Baluci,Simone Persampieri et al. Alessandro Lupi et al.
Background: Elevated low-density lipoprotein cholesterol (LDL-C) after acute coronary syndrome (ACS) significantly increases cardiovascular risk. Timely reduction of LDL-C is crucial, but it takes several weeks to achieve...
Helen Williams,Habib Francis,Jasmin Huang et al. Helen Williams et al.
Background and aims: Familial Hypercholesterolaemia (FH) is characterised by high cholesterol and premature cardiovascular disease. While hypercholesterolaemia and inflammation are both key drivers in the formation of ath...
Antonio Centola,Michelangelo Carbonara,Serena De Nuzzo et al. Antonio Centola et al.
Background: A mean relative 50 % reduction of LDL cholesterol (LDLc) levels was observed in randomized studies in patients treated with inclisiran, a small-interfering-RNA therapeutic agent that reduces hepatic synthesis ...
Farah Yasmin,Abdul Moeed,Muhammad Ahmed Ali Fahim et al. Farah Yasmin et al.
Objectives: National estimates of deaths related to cardiovascular disease (CVD) and liver cirrhosis remain ambiguous. The purpose of this study was to observe the contemporary trends in CVD and liver cirrhosis-related mo...
Amalia Despoina Koutsogianni,Fotios Barkas,Constantinos Tellis et al. Amalia Despoina Koutsogianni et al.
Background/introduction: Oxidized phospholipids (OxPLs) are bound to apolipoprotein B-100 (OxPL-apoB) and apolipoprotein(a) [OxPL-apo(a)] and are present freely within the phospholipid shell of apoB-containing lipoprotein...
Agete Tadewos Hirigo,Alemayehu Abera,Daniel Yilma et al. Agete Tadewos Hirigo et al.
Background: Inconsistent evidence on lipid alterations in people living with HIV (PLWH) on dolutegravir (DTG)-based antiretroviral therapy (ART) highlights the need for further study. This study aimed to assess the associ...